Recent trials with the solution delivered 37% improvement in available prime-time minutes over a three-month period TOKYO, Sept. 14, 2023...
Proprietary Giving-as-a-Service ('GaaS') technology uses well-being goal achievement as the key to unlock corporate dollars for employee donation to causes...
The positive opinion follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines for...
Combining the world-class clinical and research expertise of Mayo Clinic with the deep research, engineering, and product development expertise of...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Vancouver, British Columbia--(Newsfile Corp. - September 14, 2023) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or...
Sustained acoustic medicine provides proven soft tissue healing via ZetrOZ's patented wearable ultrasound unit.TRUMBULL, CT / ACCESSWIRE / September 14,...
Agreement Focuses on the Accelerated Development of LNP-encapsulated LineaDNA™ Vaccines to Eliminate the Use of Plasmid DNA and Reduce the...
MAULDIN, SC / ACCESSWIRE / September 14, 2023 / Xcelerate, Inc. (OTCQB:"XCRT") today announced that ESN Group, Inc., a subsidiary...
Click here to access webcast replayTop line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer...
ANN ARBOR, MI / ACCESSWIRE / September 14, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
IRVINE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement...
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays Cytek Reveal...
The risk-based, 2-year (r2) certification validates that the digital health management company meets security, privacy, and compliance requirements for protecting...
Investor Interest in Care Delivery and Expanded Access Marks End of “Psychedelic Winter”LONDON, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Beckley...
Less than 3% of study participants receiving medication for opioid use disorder via telehealth falsified urine drug screening results; just...
Scilex Holding Company announced completion of its SP-103 Phase 2 study to evaluate the safety and efficacy in subjects with...
HAMILTON, BERMUDA , Sept. 14, 2023 (GLOBE NEWSWIRE) -- Fresh data from randomized controlled NASAR clinical trial further demonstrate efficacy...
– Proteomics analysis showed that rencofilstat improved aberrant protein profiles in IPF tissues – – Superior effects of rencofilstat alone...
LONDON and NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an...